• No results found

Integrative network modeling of large multidimensional cancer datasets

N/A
N/A
Protected

Academic year: 2021

Share "Integrative network modeling of large multidimensional cancer datasets"

Copied!
2
0
0

Loading.... (view fulltext now)

Full text

(1)

Integrative network modeling of large multidimensional cancer datasets

Akademisk avhandling

som för avläggande av medicine doktorsexamen vid Sahlgrenska Akademin vid Göteborgs Universitet

kommer att offentligen försvaras i hörsal Waldemar Sjölander, Medicinaregatan 7A, Göteborg,

fredagen den 23 oktober 2015 kl. 9.00 av

Teresia Kling

Fakultetsopponent: Doktor Sach Mukherjee

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Avhandlingen baseras på följande delarbeten:

I. Jörnsten, R., Abenius, T., Kling, T., Schmidt, L., Johansson, E., Nordling, T. E. M., Nordlander, B., Sander, C., Gennemark, P., Funa, K., Nilsson, B., Lindahl, L., Nelander, S. Network modeling of the transcriptional effects of copy number aberrations in glioblas- toma. Molecular systems biology, 2011. 7(1), 486.

II. Kling, T.*, Ferrarese, R.*, Ó hAilín, D., Heiland, H. H., Dai, F., Vasilikos, I., Weyer- brock, A., Jörnsten, R., Carro**, M. S., Nelander, S**. Integrative modeling reveals ANXA2 as a determinant of mesenchymal transformation in glioblastoma. 2015

Submitted

*Joint first authors, **Joint last authors

III. Kling, T.*, Johansson, P.*, Sánchez, J., Marinescu, V. D., Jörnsten, R., Nelander, S. Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content. Nucleic Acids Research, 2015.

*Joint first authors

2015

(2)

Integrative network modeling of large multidimensional cancer datasets

Teresia Kling

Department of Molecular and Clinical Medicine, Institute of Medicine Sahlgrenska Academy at University of Gothenburg, Sweden

ABSTRACT

Our ability to conduct detailed molecular investigations on tissue samples have, during the past decade, enabled the formation of databases containing measurements from thousands of cancer tumors. To harness the potential of the amassing data sets, we introduce new modeling techniques and generalise existing methods for large-scale integration of cancer data. These methods aim to construct network models that link genetic, epigenetic, transcriptional and phenotypic events, by combining genome-wide measurements of multiple kinds.

In paper I we constructed a modeling framework, EPoC, for creating causal networks be- tween gene copy number levels and mRNA expression, and applied it to data from the brain tumor glioblastoma. Some of the predicted regulators were tested in four glioblastoma-derived cell lines and confirmed that the network model could be used to find unknown regulators of cell growth in glioblastoma.

In paper II we used data integrative network modeling to identify novel genomic, epige- netic and transcriptional regulators of glioblastoma subtypes. In addition to confirming known regulators of gliomagenesis, the model also predicted that Annexin A2 (ANXA2) promoter methylation and mRNA expression were linked to the signature target genes of the clinically aggressive mesenchymal molecular subtype. Our findings were validated by knockdown of ANXA2 in glioblastoma-derived cell cultures.

Paper III presents an extension of sparse inverse covariance selection (SICS), which is adapted and optimized for modeling of genetic, epigenetic, and transcriptional data across mul- tiple cancer types. To evaluate the potential of the method, we applied it to data from eight cancers available in The Cancer Genome Atlas and published the model online at cancerland- scapes.org for anyone to explore. The derived multi-cancer model detected known interactions and contained interesting predictions, including functionally coupled network structures shared between cancers.

In summary, we use network modeling of cancer to identify possible drug targets, drivers of molecular subclasses, and reveal similarities and differences between cancer types. The developed tools for network construction can assist in further investigation of the cancer genome, potentially including other data sources and additional cancer diagnoses.

Keywords: network modeling, data integration, glioblastoma, pan-cancer analysis, The Cancer Genome Atlas

ISBN: 978-91-628-9557-0 (print) ISBN: 978-91-628-9558-7 (pdf) http://hdl.handle.net/2077/39547

References

Related documents

The breast cancer microen vironment and cancer cell secretion | Emma P ersson.

Doctor-patient communication is essential for quality of health care. Little has been done about doctor-patient communication in Africa in general, and in Uganda and Ethiopia

Total cost of palbociclib per 100,000 inhabitants indicated that all the healthcare regions, except the north and the south healthcare regions showed a slow increase when the drug was

This thesis aims to address these challenges by using resampling to control the false discovery rate (FDR) of edges, by combining resampling-based network modeling with a

SASS is based on, first, repeatedly estimating networks based on random subsets of the available data (similarly to ROPE, paper I). Next, a method for community detection is

vid Göteborgs Universitet kommer att offentligen försvaras i Föreläsningssal 3, Institutionen för Odontologi, Medicinaregatan 12D, Göteborg.. Fredagen den 30 januari

T cells, IL-12, and IFN-g are required to maintain tumor cells in a state of functional dormancy, whereas NK cells and molecules that participate in the recognition or effector

Furthermore, IL-6 and IL-8 are well-known to affect the cancer stem cell propagation [76, 147, 179] and induced secretion of these cytokines could partially be responsible for